MZ-1866
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MZ-1866, covering 2026-02-23 to 2026-02-23. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1/2 Study of MZ-1866, an AAV-9 Gene Therapy Delivered by Intracerebroventricular Injection to Participants With Pitt Hopkins Syndrome [Phase 1, Phase 2]